Selectivity Life develops medical devices to improve fertility treatment accessibility and efficacy. Their patented technology offers a non-invasive method for selecting the healthiest sperm, aiming to increase fertilization success rates. The company also creates assistive devices for procedures like IUI, simplifying them for broader application.
Funding
$180K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Infertility affects approximately 20% of couples globally, representing a significant public health concern. Current assisted reproductive technologies, while advancing, often present accessibility challenges due to high costs, geographical limitations to specialized clinics, and complex procedures. This limits access for a substantial portion of the population seeking to build families.
Solution
Selectivity Life is developing medical devices to enhance the accessibility and efficacy of fertility treatments. Their core innovation is a patented, natural, and non-invasive sperm selection technology that mimics biological barriers, isolating the healthiest spermatozoa. This approach aims to improve fertilization success rates by preserving sperm DNA integrity. Additionally, the company is creating assistive devices for procedures like intrauterine insemination (IUI), simplifying the process and enabling it to be performed in less specialized settings, potentially even at home. This dual focus on advanced sperm selection and procedural simplification is designed to reduce costs and broaden access to fertility care.
Target Audience
The primary target audience includes fertility clinics, reproductive health specialists, general practitioners, and individuals or couples seeking more accessible and affordable fertility treatments.
Features
- Patented microfluidic device utilizing a specialized membrane for natural, non-invasive sperm selection.
- Technology designed to minimize reactive oxygen species and preserve sperm DNA integrity, leading to higher quality gametes.
- Device enables self-selection of spermatozoa with superior motility and morphology, enhancing fertilization potential.
- Simplified sperm selection process that reduces the need for complex laboratory equipment and specialized personnel.
- Integrated system for intrauterine insemination (IUI) procedures, including automated cervical detection and cannula guidance.
- Potential for at-home IUI application, further decentralizing fertility treatments and reducing patient stress.
- Real-time image transmission capability via a smartphone application for remote specialist assistance.
- Disposable cartridge system for the IUI device, ensuring hygiene and ease of use.
- Designed to be cost-effective, with the sperm selection component priced significantly lower than current market alternatives.